Cargando…
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
INTRODUCTION: Ataxia telangiectasia mutated and Rad3 Related (ATR) protein kinase is a key sensor of single-stranded DNA associated with stalled replication forks and repair intermediates generated during DNA repair. XRCC1 is a critical enzyme in single strand break repair and base excision repair....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581581/ https://www.ncbi.nlm.nih.gov/pubmed/23451157 http://dx.doi.org/10.1371/journal.pone.0057098 |
_version_ | 1782260443757150208 |
---|---|
author | Sultana, Rebeka Abdel-Fatah, Tarek Perry, Christina Moseley, Paul Albarakti, Nada Mohan, Vivek Seedhouse, Claire Chan, Stephen Madhusudan, Srinivasan |
author_facet | Sultana, Rebeka Abdel-Fatah, Tarek Perry, Christina Moseley, Paul Albarakti, Nada Mohan, Vivek Seedhouse, Claire Chan, Stephen Madhusudan, Srinivasan |
author_sort | Sultana, Rebeka |
collection | PubMed |
description | INTRODUCTION: Ataxia telangiectasia mutated and Rad3 Related (ATR) protein kinase is a key sensor of single-stranded DNA associated with stalled replication forks and repair intermediates generated during DNA repair. XRCC1 is a critical enzyme in single strand break repair and base excision repair. XRCC1-LIG3 complex is also an important contributor to the ligation step of the nucleotide excision repair response. METHODS: In the current study, we investigated synthetic lethality in XRCC1 deficient and XRCC1 proficient Chinese Hamster ovary (CHO) and human ovarian cancer cells using ATR inhibitors (NU6027). In addition, we also investigated the ability of ATR inhibitors to potentiate cisplatin cytotoxicity in XRCC1 deficient and XRCC1 proficient CHO and human cancer cells. Clonogenic assays, alkaline COMET assays, γH2AX immunocytochemistry, FACS for cell cycle as well as FITC-annexin V flow cytometric analysis were performed. RESULTS: ATR inhibition is synthetically lethal in XRCC1 deficient cells as evidenced by increased cytotoxicity, accumulation of double strand DNA breaks, G2/M cell cycle arrest and increased apoptosis. Compared to cisplatin alone, combination of cisplatin and ATR inhibitor results in enhanced cytotoxicity in XRCC1 deficient cells compared to XRCC1 proficient cells. CONCLUSIONS: Our data provides evidence that ATR inhibition is suitable for synthetic lethality application and cisplatin chemopotentiation in XRCC1 deficient ovarian cancer cells. |
format | Online Article Text |
id | pubmed-3581581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35815812013-02-28 Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells Sultana, Rebeka Abdel-Fatah, Tarek Perry, Christina Moseley, Paul Albarakti, Nada Mohan, Vivek Seedhouse, Claire Chan, Stephen Madhusudan, Srinivasan PLoS One Research Article INTRODUCTION: Ataxia telangiectasia mutated and Rad3 Related (ATR) protein kinase is a key sensor of single-stranded DNA associated with stalled replication forks and repair intermediates generated during DNA repair. XRCC1 is a critical enzyme in single strand break repair and base excision repair. XRCC1-LIG3 complex is also an important contributor to the ligation step of the nucleotide excision repair response. METHODS: In the current study, we investigated synthetic lethality in XRCC1 deficient and XRCC1 proficient Chinese Hamster ovary (CHO) and human ovarian cancer cells using ATR inhibitors (NU6027). In addition, we also investigated the ability of ATR inhibitors to potentiate cisplatin cytotoxicity in XRCC1 deficient and XRCC1 proficient CHO and human cancer cells. Clonogenic assays, alkaline COMET assays, γH2AX immunocytochemistry, FACS for cell cycle as well as FITC-annexin V flow cytometric analysis were performed. RESULTS: ATR inhibition is synthetically lethal in XRCC1 deficient cells as evidenced by increased cytotoxicity, accumulation of double strand DNA breaks, G2/M cell cycle arrest and increased apoptosis. Compared to cisplatin alone, combination of cisplatin and ATR inhibitor results in enhanced cytotoxicity in XRCC1 deficient cells compared to XRCC1 proficient cells. CONCLUSIONS: Our data provides evidence that ATR inhibition is suitable for synthetic lethality application and cisplatin chemopotentiation in XRCC1 deficient ovarian cancer cells. Public Library of Science 2013-02-25 /pmc/articles/PMC3581581/ /pubmed/23451157 http://dx.doi.org/10.1371/journal.pone.0057098 Text en © 2013 Sultana et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sultana, Rebeka Abdel-Fatah, Tarek Perry, Christina Moseley, Paul Albarakti, Nada Mohan, Vivek Seedhouse, Claire Chan, Stephen Madhusudan, Srinivasan Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title | Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title_full | Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title_fullStr | Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title_full_unstemmed | Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title_short | Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells |
title_sort | ataxia telangiectasia mutated and rad3 related (atr) protein kinase inhibition is synthetically lethal in xrcc1 deficient ovarian cancer cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581581/ https://www.ncbi.nlm.nih.gov/pubmed/23451157 http://dx.doi.org/10.1371/journal.pone.0057098 |
work_keys_str_mv | AT sultanarebeka ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT abdelfatahtarek ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT perrychristina ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT moseleypaul ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT albaraktinada ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT mohanvivek ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT seedhouseclaire ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT chanstephen ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells AT madhusudansrinivasan ataxiatelangiectasiamutatedandrad3relatedatrproteinkinaseinhibitionissyntheticallylethalinxrcc1deficientovariancancercells |